We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Rheumatology

Journal Scan / Research · May 11, 2021

First-Line csDMARD Monotherapy Drug Retention in Psoriatic Arthritis

Rheumatology (Oxford, England)


Additional Info

Rheumatology (Oxford, England)
First-Line csDMARD Monotherapy Drug Retention in Psoriatic Arthritis: Methotrexate Outperforms Sulfasalazine
Rheumatology (Oxford) 2021 Feb 01;60(2)780-784, ME Jacobs, JN Pouw, P Welsing, TRDJ Radstake, EFA Leijten

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading